JPMorgan Chase & Co. Issues Pessimistic Forecast for Vertex ...

JPMorgan Chase & Co. Issues Pessimistic Forecast For Vertex ...

1 day from now

5 days ago  · Scotiabank raised their price target on Vertex Pharmaceuticals from $480.00 to $486.00 and gave the stock a "sector perform" rating in a research report on Tuesday, …

marketbeat.com

Bank Of America Issues Pessimistic Forecast For Vertex …

1 day from now

Dec 21, 2024  · Other research analysts have also issued reports about the stock. HC Wainwright reissued a “buy” rating and set a $600.00 price objective on shares of Vertex Pharmaceuticals …

defenseworld.net

HC Wainwright Has Lowered Expectations For Vertex ... - MarketBeat

1 day from now

Dec 20, 2024  · HC Wainwright decreased their price objective on shares of Vertex Pharmaceuticals from $600.00 to $535.00 and set a "buy" rating for the company in a report …

marketbeat.com

Vertex Price Target Lowered To $535 From $600 At H.C. Wainwright

1 day from now

Dec 20, 2024  · H.C. Wainwright analyst Andrew Fein lowered the firm’s price target on Vertex Pharmaceuticals (VRTX) to $535 from $600 and keeps a Buy rating on the shares after the …

nasdaq.com

VRTX Stock Price Target | Vertex Pharmaceuticals Analyst Ratings

1 day from now

Rating by Andrew Fein at HC Wainwright. 8/5/2022: Barclays: Boost Target: Overweight: $291.00 $307.00: i. 7/26/2022: Piper Sandler: Boost Target: Neutral: $242.00 $256.00: i. ... Truist …

pricetargets.com

Bridgewater Associates LP Sells 29,777 Shares Of Vertex …

1 day from now

Dec 2, 2024  · Get Our Latest Stock Report on Vertex Pharmaceuticals. Vertex Pharmaceuticals Stock Performance. VRTX stock opened at $468.13 on Monday. The company has a debt-to …

etfdailynews.com

Citigroup Issues Positive Forecast For Vertex (NASDAQ:VERX) Stock …

1 day from now

Dec 18, 2024  · Vertex (NASDAQ:VERX – Get Free Report) had its target price hoisted by research analysts at Citigroup from $46.00 to $54.00 in a research report issued to clients and …

americanbankingnews.com

HC Wainwright Reiterates Buy Rating For Kopin (NASDAQ:KOPN)

1 day from now

Nov 15, 2024  · KOPN opened at $0.89 on Wednesday. Kopin has a 1-year low of $0.56 and a 1-year high of $2.82. The company has a market capitalization of $108.18 million, a PE ratio of …

defenseworld.net

HC Wainwright Issues Pessimistic Forecast For IN8bio …

1 day from now

Nov 14, 2024  · IN8bio (NASDAQ:INAB – Free Report) had its target price reduced by HC Wainwright from $12.50 to $8.00 in a research note issued to investors on Wednesday …

modernreaders.com

HC Wainwright Issues Pessimistic Forecast For Gevo Earnings

1 day from now

Nov 11, 2024  · HC Wainwright analyst A. Dayal now anticipates that the energy company will post earnings per share of $0.40 for the year, down from their prior estimate of $0.46. HC …

marketbeat.com

HC Wainwright Issues Pessimistic Forecast For ELDN Earnings

1 day from now

Nov 22, 2024  · HC Wainwright analyst V. Bernardino now expects that the company will earn ($0.32) per share for the quarter, down from their previous estimate of ($0.22). HC Wainwright …

marketbeat.com

HC Wainwright Issues Pessimistic Forecast For ETON Earnings

1 day from now

Nov 27, 2024  · HC Wainwright analyst S. Ramakanth now expects that the company will post earnings of $0.05 per share for the quarter, down from their previous estimate of $0.09. HC …

marketbeat.com

HC Wainwright Issues Pessimistic Forecast For Keros Therapeutics ...

1 day from now

Dec 13, 2024  · HC Wainwright reduced their target price on shares of Keros Therapeutics from $100.00 to $47.00 and set a "buy" rating for the company in a research report on Friday. ... HC …

marketbeat.com